AtriCure Inc reports results for the quarter ended in March - Earnings Summary

AtriCure

01/05/2024 22:02

* AtriCure Inc  ATRC.OQ  reported a quarterly adjusted loss
of 28
cents​​ per share for the quarter ended in March, lower than the
same quarter last year, when the company reported EPS of -23
cents.  The mean expectation of nine analysts for the quarter
was for a loss of 23 cents per share. Wall Street expected
results to range from -30 cents to -20 cents per share.
    * Revenue rose 16.4% to $108.85 million from a year ago;
analysts
expected $106.90 million. 
    * AtriCure Inc's reported EPS for the quarter was a loss
of 28
cents​.
    * The company reported a quarterly loss of $13.27 million.
    * AtriCure Inc shares had fallen by 20.7% this quarter and
lost 32.4% so far this year.

FORECAST CHANGES
    * The mean earnings estimate of analysts had fallen by
about 14.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 9 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the medical
equipment,
supplies & distribution peer group is also "buy"

Wall Street's median 12-month price target for AtriCure Inc is
$57.50 
This summary was machine generated from LSEG data May 1 at 09:02
p.m. UTC. ​All figures in US dollars unless otherwise stated.
(For questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2024      -0.23          -0.28          Missed
 Dec. 31 2023      -0.23          -0.21          Beat
 Sep. 30 2023      -0.31          -0.20          Beat
 Jun. 30 2023      -0.30          -0.11          Beat